Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum
D. H. Yoon, M. H. Ryu, Y. S. Park, H. J. Lee, C. Lee, B. Y. Ryoo, J. L. Lee, H. M. Chang, T. W. Kim, Y. K. Kang
Dive into the research topics of 'Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum'. Together they form a unique fingerprint.